
It is shifting the 20 kilolitre production facility and the R&D centre from Egattur to a new facility at Alathur, where it has a drug intermediate and custom synthesis facility. For LIC, this is the second major acquisition in Chennai over last one year. Last year it acquired a 3-acre property at Pallavaram, a Chennai suburb, from Hindustan Unilever Ltd for over Rs 60 crore. LIC has announced major plans to exploit its existing real estate holdings and add to its property by acquiring prime property in major urban centres. Both the properties were marketed by Cushman & Wakefield, international property consultants.
Source: The Hindu
No comments:
Post a Comment